Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26504586 |
CA |
72 | |
Influenza, Dehydration, Condition aggravated, Dyspnoea, Asthenia, Oropharyngeal pain, Off label use, Drug ineffective, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 302 | 26504858 |
US |
27 | |
Influenza, Product dose omission issue, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 303 | 26505051 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN, ROSUVASTATIN CALCIUM, USTEKINUMAB, LEVOTHYROXINE SODIUM, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 304 | 26505244 |
MX |
3 | 2 |
Crying, Restlessness, Constipation, Influenza, Flatulence, Reflux gastritis, Discomfort, Amoebiasis, |
||||
PALIVIZUMAB, AMOXICILLIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 305 | 26505526 |
US |
61 | 2 |
Influenza, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 306 | 26505865 |
CA |
59 | |
Upper respiratory tract congestion, Cold urticaria, Feeling abnormal, Condition aggravated, Cough, Ear pain, Oropharyngeal pain, Malaise, Hypersomnia, Ear pain, Sinus congestion, Peripheral swelling, Dysstasia, Abdominal discomfort, Oropharyngeal erythema, Pain in extremity, Facial pain, Sinus pain, Cystitis, Cystitis, Pharyngitis streptococcal, Influenza, Pain, Pneumonia, Headache, Sinusitis, Dry skin, Rash, Pruritus, Fatigue, Chest pain, Nausea, Therapeutic product effect decreased, Therapeutic response shortened, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DIPHENHYDRAMINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 307 | 26506216 |
US |
45 | 2 |
Hypophagia, Decreased appetite, COVID-19, Influenza, Fatigue, Asthenia, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 308 | 26506399 |
US |
52 | 2 |
Nephrolithiasis, Influenza, Hyperhidrosis, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 309 | 26506542 |
40 | ||
Influenza, Product dose omission issue, Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 310 | 26506663 |
GB |
2 | |
Lower respiratory tract infection viral, Influenza, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 311 | 26506809 |
60 | ||
Appendicectomy, Appendicitis, Influenza, Arthritis, Arthralgia, Product dispensing issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CALCIUM, FOLIC ACID, |
||||
| 312 | 26506946 |
US |
77 | |
Influenza, |
||||
DULAGLUTIDE, |
||||
| 313 | 26507073 |
EU |
58 | 2 |
Renal failure, Influenza, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 314 | 26509184 |
1 | ||
Pneumonia, Influenza, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB, ADALIMUMAB, |
||||
| 315 | 26509472 |
1 | ||
Influenza, Pneumonia, |
||||
DORNASE ALFA, |
||||
| 316 | 26510181 |
|||
Influenza, Myalgia, Ovarian cancer, |
||||
MACITENTAN, |
||||
| 317 | 26510191 |
|||
Influenza, Myalgia, Ovarian cancer, |
||||
TADALAFIL, |
||||
| 318 | 26498399 |
GB |
2 | |
Sepsis, Lower respiratory tract infection, Burning sensation, Headache, Fatigue, COVID-19, Nasopharyngitis, Influenza, Norovirus infection, Malaise, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 319 | 26498418 |
US |
79 | 1 |
Influenza, |
||||
POMALIDOMIDE, ACYCLOVIR, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FUROSEMIDE, IRON, LOVASTATIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, CETIRIZINE HYDROCHLORIDE, |
||||
| 320 | 26498532 |
US |
||
Pulmonary congestion, Nasopharyngitis, Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, BUSPIRONE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MACITENTAN, OXYGEN, 0XYGEN, DAPAGLIFLOZIN, TORSEMIDE, |
||||
| 321 | 26498605 |
US |
48 | |
Influenza, |
||||
OMAVELOXOLONE, |
||||
| 322 | 26498631 |
CA |
36 | 2 |
Multiple sclerosis, Influenza, Tremor, Pruritus, Rash, |
||||
ZOLEDRONIC ACID, |
||||
| 323 | 26498900 |
US |
2 | |
Seizure, Nausea, Gastrointestinal disorder, Drug intolerance, Vomiting, Diarrhoea, Influenza, Gait disturbance, Electroencephalogram abnormal, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, OXCARBAZEPINE, |
||||
| 324 | 26499015 |
EU |
72 | 2 |
Coma, Influenza, Pneumonia, Staphylococcal infection, |
||||
LENALIDOMIDE, BORTEZOMIB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PYRIDOXINE HYDROCHLORIDE, |
||||
| 325 | 26499386 |
US |
30 | 1 |
COVID-19, Pneumonia, Influenza, |
||||
VIMSELTINIB, |
||||
| 326 | 26499565 |
1 | ||
Influenza, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 327 | 26499662 |
CA |
1 | |
Lower respiratory tract infection, Influenza, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 328 | 26499678 |
CA |
59 | 2 |
Muscle strain, Vulvovaginal burning sensation, Vulvovaginal pain, Head injury, Contusion, Ligament sprain, Joint swelling, Fall, Burning sensation, Arthralgia, Pain in extremity, Gait disturbance, Hypokinesia, Arthritis, Bowel movement irregularity, Urinary tract infection, Migraine, Migraine, Electric shock sensation, Seasonal allergy, Nasal congestion, Abdominal distension, Insomnia, Musculoskeletal discomfort, Joint range of motion decreased, Peripheral swelling, Peripheral coldness, Vitreous floaters, Poor venous access, Alopecia, Groin pain, Mobility decreased, Vision blurred, Visual impairment, Joint stiffness, Abdominal discomfort, Pain in extremity, Nausea, Hypoaesthesia, Abdominal pain, Paraesthesia, Pain, Fatigue, Headache, Incorrect drug administration rate, Nasopharyngitis, Oropharyngeal pain, Secretion discharge, Mass, Influenza, Pain, Skin swelling, Respiratory tract congestion, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SOTALOL HYDROCHLORIDE, PREGABALIN, METOPROLOL TARTRATE, METOPROLOL, COLCHICINE, BISOPROLOL FUMARATE, CANDESARTAN, NAPROXEN, NAPROXEN SODIUM, UBROGEPANT, UBROGEPANT, BACLOFEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 329 | 26499788 |
GB |
2 | |
Lower respiratory tract infection, Malaise, Nasopharyngitis, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 330 | 26500213 |
US |
80 | 2 |
Influenza, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 331 | 26500271 |
US |
5 | 1 |
Influenza, Pyrexia, |
||||
CANAKINUMAB, |
||||
| 332 | 26500273 |
GB |
66 | 2 |
Influenza, Lower respiratory tract infection, Cough, Urinary tract infection, Haemorrhage urinary tract, Muscular weakness, Muscle spasticity, Lymphocyte count decreased, Muscle spasms, Muscle rigidity, Gait inability, |
||||
SIPONIMOD, SIPONIMOD, SIPONIMOD, |
||||
| 333 | 26500312 |
CA |
1 | |
Weight decreased, Nausea, Vomiting, Influenza, |
||||
VEDOLIZUMAB, |
||||
| 334 | 26500381 |
21 | ||
Influenza, Dyspnoea, Product dose omission in error, Therapy interrupted, Product availability issue, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 335 | 26500730 |
PE |
57 | 2 |
Hypotonia, Sicca syndrome, Osteoporosis postmenopausal, Zinc metabolism disorder, Gastroenteritis viral, Ill-defined disorder, Pain in extremity, Arthralgia, Hypothyroidism, Alopecia universalis, Osteoporosis, Alopecia, Therapy partial responder, Osteoporosis, Influenza, Pyrexia, Oropharyngeal pain, Sjogren^s syndrome, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, DEFLAZACORT, CELECOXIB, CELECOXIB, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ZOLEDRONIC ACID, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 336 | 26501170 |
US |
17 | 1 |
Injection site cellulitis, Injection site reaction, Injection site pain, Injection site swelling, Injection site warmth, Injection site bruising, Injection site erythema, Erythema, Hypersensitivity, Influenza, Pyrexia, Lethargy, Pain, Dizziness, Off label use, |
||||
PEGVALIASE-PQPZ, FAMOTIDINE, LORATADINE, LORATADINE TABLET, PREDNISONE, |
||||
| 337 | 26501457 |
US |
||
Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 338 | 26501615 |
US |
40 | 2 |
Bronchiectasis, Mast cell activation syndrome, Pneumonia influenzal, Productive cough, Influenza, Norovirus infection, Postural orthostatic tachycardia syndrome, Vomiting, Arthralgia, Rhinitis, Ear pain, Toothache, Dizziness, |
||||
ASFOTASE ALFA, |
||||
| 339 | 26501774 |
US |
55 | 2 |
Surgery, Influenza, Dehydration, Condition aggravated, Illness, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 340 | 26501800 |
CA |
40 | 2 |
Influenza, Pharyngitis streptococcal, Abdominal pain upper, Diarrhoea, Decreased appetite, |
||||
INFLIXIMAB, AMOXICILLIN, |
||||
| 341 | 26501990 |
US |
64 | 2 |
Influenza, |
||||
LENALIDOMIDE, |
||||
| 342 | 26502102 |
US |
74 | 1 |
Influenza, Escherichia test positive, |
||||
ENASIDENIB MESYLATE, ENASIDENIB MESYLATE, VENETOCLAX, |
||||
| 343 | 26502727 |
US |
24 | 2 |
Migraine, Vulvovaginal candidiasis, Vitamin D decreased, Influenza, Bronchitis, Sinusitis, |
||||
NUSINERSEN, ZOLMITRIPTAN, DROSPIRENONE, PANTOPRAZOLE, SPIRONOLACTONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, NAPROXEN, NAPROXEN SODIUM, |
||||
| 344 | 26505021 |
68 | 1 | |
Influenza, Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 345 | 26497443 |
CA |
57 | |
Sjogren^s syndrome, Migraine with aura, Head discomfort, Fear of injection, Pruritus, Urticaria, Dyspepsia, Fatigue, Influenza, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, MONTELUKAST, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 346 | 26497620 |
US |
80 | 2 |
Diarrhoea, Fatigue, Feeling abnormal, Sinus headache, Dyspnoea exertional, Influenza, |
||||
MAVACAMTEN, |
||||
| 347 | 26497641 |
US |
1 | |
Influenza, |
||||
DUPILUMAB, |
||||
| 348 | 26497778 |
US |
||
Influenza, Oropharyngeal pain, Pain, Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 349 | 26500498 |
32 | 2 | |
Streptococcal infection, Therapy interrupted, Influenza, Gastroenteritis viral, Tubo-ovarian abscess, |
||||
UPADACITINIB, |
||||
| 350 | 26496746 |
US |
65 | 2 |
Renal failure, Influenza, Off label use, |
||||
RISANKIZUMAB-RZAA, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 351 | 26496756 |
US |
||
Dyspnoea, Nasopharyngitis, Influenza, Illness, Decreased immune responsiveness, Oropharyngeal pain, Upper-airway cough syndrome, Nasal congestion, Dry eye, Hypersomnia, Fatigue, Headache, Limb discomfort, Dizziness, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 352 | 26496882 |
US |
||
Influenza, No adverse event, |
||||
RAVULIZUMAB, ECULIZUMAB, |
||||
| 353 | 26496994 |
US |
53 | 2 |
Sinus disorder, Influenza, |
||||
ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MODAFINIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, NALTREXONE, |
||||
| 354 | 26497054 |
US |
64 | 2 |
Influenza, Autoimmune disorder, Hospitalisation, Pneumonia, Product dose omission issue, Erythema, Butterfly rash, Illness, Feeling hot, Pain, Fatigue, Product use in unapproved indication, |
||||
BELIMUMAB, BELIMUMAB, |
||||
| 355 | 26497130 |
JP |
13 | 2 |
Influenza, Nephrogenic anaemia, Drug dose titration not performed, |
||||
FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, SOMATROPIN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, AMLODIPINE, DARBEPOETIN ALFA, DIPYRIDAMOLE, DARBEPOETIN ALFA, |
||||
| 356 | 26497141 |
JP |
58 | 1 |
Influenza, Cough, Productive cough, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 357 | 26497142 |
US |
||
Influenza, |
||||
NUSINERSEN, |
||||
| 358 | 26497351 |
47 | ||
Influenza, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 359 | 26491957 |
CA |
61 | 2 |
Asthenia, COVID-19, Clostridium difficile colitis, Disturbance in attention, Dyspnoea, Illness, Irregular sleep phase, Malaise, Muscle spasms, Peripheral swelling, Pruritus, Tachycardia, Cataract, Constipation, Diarrhoea, Dysgeusia, General physical health deterioration, Influenza, Liver function test increased, Lymphadenopathy, Nausea, Urinary tract infection bacterial, Pneumonia, Rash pruritic, Sleep disorder, Abdominal discomfort, Somnambulism, Disease progression, Inappropriate schedule of product administration, Product dose omission issue, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, SEMAGLUTIDE, |
||||
| 360 | 26492133 |
68 | ||
Device issue, Product dose omission issue, Peripheral swelling, Pain in extremity, Myalgia, Influenza, Rhinorrhoea, Eye pruritus, Anxiety, Irritability, Fatigue, Diarrhoea, Needle issue, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, DULAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 361 | 26492165 |
1 | ||
Weight decreased, Pneumonia, Influenza, |
||||
VIGABATRIN, |
||||
| 362 | 26492629 |
CA |
2 | |
Influenza, Pneumonia, Abdominal discomfort, Temperature regulation disorder, |
||||
ZOLEDRONIC ACID, |
||||
| 363 | 26492779 |
US |
68 | 1 |
Illness, Influenza, Product dose omission issue, |
||||
RELUGOLIX, RELUGOLIX, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DAROLUTAMIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 364 | 26492845 |
US |
||
Influenza, Cystic fibrosis, Infection, |
||||
TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, PANCRELIPASE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, |
||||
| 365 | 26493033 |
JP |
||
Respiratory tract infection viral, Enteritis infectious, Viral skin infection, Cholangitis, Otitis media, Skin infection, Soft tissue infection, Tonsillitis, Constipation, Ileus, Pneumonia bacterial, Haematological infection, Liver transplant rejection, Urinary tract infection, Hypertensive encephalopathy, Adenovirus infection, HCoV-OC43 infection, Parainfluenzae virus infection, Rhinovirus infection, Influenza, Respiratory syncytial virus infection, Human herpesvirus 7 infection, Cytomegalovirus infection, Enterovirus infection, Pneumococcal infection, Enterobacter infection, Staphylococcal infection, Klebsiella infection, Moraxella infection, Enterococcal infection, Escherichia infection, Beta haemolytic streptococcal infection, Rotavirus infection, Varicella zoster virus infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CYCLOSPORINE, PREDNISONE, |
||||
| 366 | 26493044 |
US |
2 | |
Influenza, Product dose omission issue, Expired product administered, |
||||
TROFINETIDE, |
||||
| 367 | 26493092 |
US |
71 | 2 |
Pneumonia, Influenza, |
||||
DUPILUMAB, |
||||
| 368 | 26493258 |
US |
||
Infusion site extravasation, Influenza, |
||||
USTEKINUMAB, |
||||
| 369 | 26493348 |
US |
71 | 1 |
Eye disorder, Pneumonia, Influenza, |
||||
POMALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IXAZOMIB, |
||||
| 370 | 26493403 |
CA |
60 | 2 |
Pneumonia, Influenza, |
||||
DUPILUMAB, DUPILUMAB, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, GABAPENTIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MONTELUKAST SODIUM, |
||||
| 371 | 26493706 |
US |
1 | |
Influenza, |
||||
RAVULIZUMAB, |
||||
| 372 | 26493728 |
CA |
2 | |
Lower respiratory tract infection, Nasopharyngitis, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, RABEPRAZOLE, PREGABALIN, |
||||
| 373 | 26493907 |
US |
56 | 2 |
Influenza, Gastroenteritis viral, Weight decreased, Eating disorder, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 374 | 26494178 |
GB |
1 | |
Hip fracture, Injection site discharge, Wrong technique in product usage process, Fall, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 375 | 26494301 |
CA |
56 | 2 |
Off label use, Fatigue, Eating disorder, Gingival pain, Mucosal pain, Respiratory tract infection, Influenza, Fatigue, Dyspnoea, Headache, Oropharyngeal pain, Drug ineffective, Neoplasm, Drug ineffective, Epistaxis, Eczema eyelids, Oral discomfort, Headache, Gait disturbance, Tongue neoplasm, Eyelids pruritus, Fatigue, Dizziness, Nausea, Hypertension, Gingival erosion, Tooth erosion, Nasal crusting, Low density lipoprotein increased, Bone density decreased, Pemphigus, Gingival pain, Neutralising antibodies positive, Epistaxis, Nasal disorder, Gingival erosion, |
||||
RITUXIMAB, OBINUTUZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, CALCIUM, CORTISOL, HYDROCORTISONE, DULOXETINE HYDROCHLORIDE, DESONIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HUMAN IMMUNOGLOBULIN G, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, NAPROXEN, NAPROXEN SODIUM, MOMETASONE FUROATE, PREDNISONE, PROGESTERONE, METHYLPREDNISOLONE SODIUM SUCCINATE, DESOXIMETASONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 376 | 26494366 |
US |
54 | 2 |
Gastroenteritis viral, Influenza, White blood cell count decreased, |
||||
ABEMACICLIB, |
||||
| 377 | 26494445 |
CA |
75 | 1 |
Influenza, Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, DUPILUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 378 | 26494614 |
US |
80 | 1 |
Influenza, |
||||
LENALIDOMIDE, |
||||
| 379 | 26495334 |
2 | ||
Arthralgia, Influenza, |
||||
LEVONORGESTREL, |
||||
| 380 | 26495374 |
US |
57 | 2 |
Influenza, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 381 | 26495577 |
US |
||
Influenza, Treatment noncompliance, Rhinorrhoea, Headache, Dizziness, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CARVEDILOL, FAMOTIDINE, FUROSEMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MAGNESIUM OXIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, TADALAFIL, GABAPENTIN, NIFEDIPINE, MINOCYCLINE HYDROCHLORIDE, AMLODIPINE BESYLATE, ONDANSETRON HYDROCHLORIDE, BENZONATATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, LORATADINE, LORATADINE ORAL, LISINOPRIL, NINTEDANIB, SPIRONOLACTONE, SILDENAFIL CITRATE, SILDENAFIL, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, ERGOCALCIFEROL, ACYCLOVIR, AZATHIOPRINE, AZELASTINE HYDROCHLORIDE, AZELASTINE, |
||||
| 382 | 26495580 |
US |
5 | 1 |
Pyrexia, Influenza, Product dose omission issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 383 | 26495757 |
CA |
2 | |
Pneumonia, Asthma, Nasopharyngitis, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ROSUVASTATIN, DIMENHYDRINATE, |
||||
| 384 | 26495771 |
|||
Influenza, Pain, Rash, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 385 | 26495925 |
US |
36 | 2 |
Malaise, Influenza, |
||||
SIBEPRENLIMAB, |
||||
| 386 | 26495969 |
1 | ||
Influenza, Immunodeficiency, |
||||
SARGRAMOSTIM, FILGRASTIM-SNDZ, |
||||
| 387 | 26495970 |
1 | ||
Influenza, Immunodeficiency, |
||||
PEGFILGRASTIM-JMDB, FILGRASTIM-SNDZ, SARGRAMOSTIM, |
||||
| 388 | 26496081 |
83 | 1 | |
Influenza, Cardiac failure, Ejection fraction decreased, |
||||
DAROLUTAMIDE, AMLODIPINE, |
||||
| 389 | 26496308 |
KR |
2 | |
Hepatic steatosis, Herpes simplex, Dyshidrotic eczema, Herpes virus infection, Dermatitis atopic, Hepatic steatosis, Inflammation, Laryngitis, Vision blurred, Acne, Pyrexia, Nasopharyngitis, Body temperature fluctuation, Influenza, Drug ineffective, Pyrexia, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 390 | 26496384 |
US |
1 | |
Influenza, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 391 | 26496641 |
US |
62 | 2 |
Blood calcium increased, Influenza, |
||||
RISANKIZUMAB-RZAA, |
||||
| 392 | 26500446 |
58 | 2 | |
Influenza, |
||||
EVOLOCUMAB, |
||||
| 393 | 26485333 |
US |
79 | 1 |
Influenza, Pneumonia, |
||||
VENETOCLAX, PRAVASTATIN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, BUSPIRONE HYDROCHLORIDE, AMLODIPINE BESYLATE, FUROSEMIDE, LACOSAMIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, DIVALPROEX SODIUM, ALPRAZOLAM, ALLOPURINOL, WARFARIN SODIUM, WARFARIN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MELATONIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 394 | 26485339 |
US |
46 | |
Influenza, Pyrexia, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 395 | 26485718 |
US |
12 | 1 |
Pneumonia, Pharyngitis streptococcal, Influenza, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 396 | 26485871 |
US |
77 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 397 | 26485876 |
CA |
3 | 1 |
Drug effective for unapproved indication, Epstein-Barr virus infection reactivation, Immunosuppression, Influenza, Off label use, Post transplant lymphoproliferative disorder, Warm autoimmune haemolytic anaemia, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOSPORINE, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 398 | 26486094 |
CA |
70 | 2 |
Influenza, Nausea, Pancytopenia, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 399 | 26486393 |
US |
11 | 2 |
Influenza, Drug hypersensitivity, Inappropriate schedule of product administration, Underdose, |
||||
TROFINETIDE, OSELTAMIVIR PHOSPHATE, |
||||
| 400 | 26486460 |
US |
57 | 2 |
Pneumonia, Urticaria, Scratch, Influenza, Asthma, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
